Inhibition of human and guinea pig complement by heparin fractions differing in affinity for antithrombin III or in average molecular weight
- 31 December 1985
- journal article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 7 (2) , 271-280
- https://doi.org/10.1016/0192-0561(85)90036-0
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Heparin prevents formation of the human C3 amplification convertase by inhibiting the binding site for B on C3bMolecular Immunology, 1983
- Structural Determinants of the Capacity of Heparin to Inhibit the Formation of the Human Amplification C3 ConvertaseJournal of Clinical Investigation, 1981
- Effect of Heparin and Heparin Fractions on Platelet AggregationJournal of Clinical Investigation, 1980
- Inhibition of the Interaction between the Complement Component Clq and Immune ComplexesInternational Archives of Allergy and Immunology, 1979
- Anticoagulant activity of heparin: Separation of high‐activity and low‐activity heparin species by affinity chromatography on immobilized antithrombinFEBS Letters, 1976
- The separation of active and inactive forms of heparinBiochemical and Biophysical Research Communications, 1976
- Inactivator of the First Component of Human Complement (CĪINA)International Archives of Allergy and Immunology, 1976
- COMPLEMENT AS A MEDIATOR OF INFLAMMATIONThe Journal of Experimental Medicine, 1967
- The Discovery of HeparinCirculation, 1959
- Anticomplementary Power of HeparinThe Journal of Infectious Diseases, 1929